(1 - 12 from 13
)
ReCor Medical initiates PARADISE system post-market study in high...
www.news-medical.net
· ReCor Medical initiates PARADISE system post-market study in high ... noninvasive treatment option to reduce their blood pressure," said Mano Iyer, ...
Otsuka Finds Paradise in Renal Denervation Market | mddionline.com
www.mddionline.com
Otsuka Holdings is set to acquire ReCor Medical for an undisclosed sum and follows Medtronic in a bid to get a renal denervation device on the market.
ReCor Medical receives the CE mark for its second generation ...
cardiovascularnews.com
“The benefit of ReCor's ultrasound approach is three-fold,” explained Mano Iyer, CEO of ReCor Medical. “Firstly, Paradise is designed to ...
ReCor Medical announces CE mark approval for its novel PARADISE™...
www.tctmd.com
... to offer a minimally invasive ultrasound therapy to resistant hypertension patients to help reduce their blood pressure,” said Mano Iyer, CEO, ...
sorted by relevance / date